Population
Patients with ischaemic heart disease and control subjects
Design
Editorial
Authors
Loading...
Highlights the presence of marked and long-lasting sympathetic overactivity following myocardial infarction, supporting the rationale for beta-blockade in these patients.
Highlights the presence of marked and long-lasting sympathetic overactivity following myocardial infarction, supporting the rationale for beta-blockade in these patients.
Malliani et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: